The Atlanta Braves recently extended Chris Sale’s contract with a one-year, $27 million deal, according to ESPN’s MLB insider Jeff Passan. This move has sparked debates among fans, especially in light of Max Fried’s departure from the team and subsequent large contract with the New York Yankees. The focus on Max Fried contract controversy centers on the Braves’ decision-making amid contrasting player commitments.
Fan Reactions to Chris Sale’s Contract Extension
The Braves’ choice to invest in the 36-year-old Sale has divided fans on social media. Some highlight Sale’s distinguished career and recent success, while others express concerns over his age and substantial injury history. Sale’s ability to perform well despite setbacks has impressed many, as one fan remarked,
“Worth every penny, still shocked the second half of his career has been so dominant,”
illustrating continued confidence in his pitching.
However, skepticism remains about the financial risks. Another fan commented,
“Atlanta betting on upside and experience. If Chris Sale stays healthy this is a steal, if not this is expensive nostalgia. Braves clearly believe the arm still plays.”
Questions also arose about Fried’s contract situation, with fans asking,
“So we can pay Sale $27 and $30M but can’t pay Max Fried $27M?,”
underscoring the perceived inconsistency in the Braves’ roster decisions.
Max Fried’s Departure and Its Impact
Max Fried, who played for the Braves since 2017, was not re-signed despite strong performance statistics. In December 2024, Fried signed an eight-year, $218 million extension with the New York Yankees, positioning him as one of the highest-paid pitchers in the league. The disparity between Fried’s and Sale’s contracts has become a focal point for criticism, reflecting broader questions about the Braves’ investment priorities.
Amid these discussions, some fans remain critical of Sale’s injury record, referring to him as a “Glass man” due to multiple injuries from 2018 to 2023, which included Tommy John surgery and fractures from a biking accident. This history adds complexity to the Braves’ willingness to commit substantial funds to Sale.
Details of Chris Sale’s Contract and Career Highlights
Chris Sale joined the Braves in December 2023 after a trade from the Boston Red Sox. In January 2024, the Braves signed him to a two-year, $38 million extension and then picked up an $18 million club option for 2026 later that year. Additionally, Sale’s latest deal includes a $30 million club option for 2028, according to Passan.
Sale’s career includes notable contracts such as a five-year, $32.5 million extension with the Chicago White Sox in 2013 and a five-year, $145 million deal with the Red Sox in 2019. As a nine-time All-Star and 2018 World Series champion, Sale has earned multiple accolades, including leading the league in strikeouts in 2015, 2017, and 2024.
Sale experienced a career resurgence in 2024, earning the National League Comeback Player of the Year award, his first Gold Glove, and an All-MLB First Team selection. These achievements reinforced the Braves’ decision to retain him despite concerns about his durability.
Broader Context: MLB Contract Trends and Potential Lockout
Fans have also noted a trend of teams offering large future salaries, sometimes speculating that these commitments might be avoided due to anticipated labor disputes. One fan observed,
“Owners are throwing out huge 2027 salaries knowing they won’t have to pay it,”
referring to the expected expiration of the collective bargaining agreement in December 2026 and the possibility of a lockout before the 2027 season.
This situation highlights the uncertainties teams face when negotiating long-term contracts, affecting decisions like those surrounding Sale and Fried. The Braves’ willingness to commit to Sale amid these dynamics suggests confidence in his immediate contribution, whereas Fried’s absence raises questions about their long-term pitching strategy.
